Onconetix, Inc. (ONCO)
NASDAQ: ONCO · IEX Real-Time Price · USD
+0.019 (14.61%)
At close: May 22, 2024, 4:00 PM
+0.001 (0.33%)
After-hours: May 22, 2024, 6:44 PM EDT

Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $3.42 million. The enterprise value is $14.35 million.

Market Cap 3.42M
Enterprise Value 14.35M

Important Dates

The last earnings date was Monday, May 20, 2024, after market close.

Earnings Date May 20, 2024
Ex-Dividend Date n/a

Share Statistics

Onconetix has 22.32 million shares outstanding. The number of shares has increased by 39.20% in one year.

Shares Outstanding 22.32M
Shares Change (YoY) +39.20%
Shares Change (QoQ) +16.02%
Owned by Insiders (%) 20.57%
Owned by Institutions (%) 14.87%
Float 21.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.50
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 18.91
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio 0.29
Quick Ratio 0.22
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -41.24

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -83.00%
Return on Capital (ROIC) n/a
Revenue Per Employee $63,242
Profits Per Employee -$3.81M
Employee Count 12
Asset Turnover 0.01
Inventory Turnover n/a


Income Tax -134,160
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -83.72% in the last 52 weeks. The beta is 3.35, so Onconetix's price volatility has been higher than the market average.

Beta (1Y) 3.35
52-Week Price Change -83.72%
50-Day Moving Average 0.14
200-Day Moving Average 0.33
Relative Strength Index (RSI) 59.43
Average Volume (30 Days) 713,037

Short Selling Information

The latest short interest is 56,021, so 0.25% of the outstanding shares have been sold short.

Short Interest 56,021
Short Previous Month 476,110
Short % of Shares Out 0.25%
Short % of Float 0.26%
Short Ratio (days to cover) 0.11

Income Statement

In the last 12 months, Onconetix had revenue of $758,898 and -$45.68 million in losses. Loss per share was -$2.51.

Revenue 758,898
Gross Profit -938,165
Operating Income -44.27M
Pretax Income -45.82M
Net Income -45.68M
EBITDA -44.48M
EBIT -44.73M
Loss Per Share -$2.51
Full Income Statement

Balance Sheet

The company has $4.46 million in cash and $15.40 million in debt, giving a net cash position of -$10.94 million or -$0.49 per share.

Cash & Cash Equivalents 4.46M
Total Debt 15.40M
Net Cash -10.94M
Net Cash Per Share -$0.49
Equity / Book Value -21.53M
Book Value Per Share -0.96
Working Capital -15.14M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.37 million and capital expenditures -$57,803, giving a free cash flow of -$14.42 million.

Operating Cash Flow -14.37M
Capital Expenditures -57,803
Free Cash Flow -14.42M
FCF Per Share -$0.65
Full Cash Flow Statement


Gross margin is -123.62%, with operating and profit margins of -5,833.24% and -6,019.47%.

Gross Margin -123.62%
Operating Margin -5,833.24%
Pretax Margin -6,037.15%
Profit Margin -6,019.47%
EBITDA Margin -5,861.42%
EBIT Margin -5,894.22%
FCF Margin -1,900.76%

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -39.20%
Shareholder Yield -39.20%
Earnings Yield -1,337.42%
FCF Yield -422.31%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Onconetix has an Altman Z-Score of -3.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.39
Piotroski F-Score 1